Venrock Adviser, LLC: holdings and changes

Number 2 of the top 100 funds by copy return. Venrock Adviser, LLC reported 34 US stocks worth $2.1B for the quarter ending 2026-09-30 and changed 7 new, 6 added, 5 trimmed and 6 sold since 2026-06-30.

Copy return, 4 quarters+131.9%
US 500, same time+14.5%
Size$2.1B
Stocks34

Holdings

StockChangeWeightValueShares
ORKA
Oruka Therapeutics INC
16.79%$346M4,148,428
ERAS
Erasca INC Com
ADD +12%14.31%$294M20,089,932
AEGLEA BIOTHER
Aeglea Biotherapeutics INC
TRIM -17%10.75%$221M2,485,448
KRSA
Korsana Biosciences INC
BUY7.07%$146M4,549,585
SVRA
Savara INC
ADD +33%4.91%$101M19,568,534
OCUL
Ocular Therapeutix INC
3.86%$79M10,346,926
DMRA
Damora Therapeutics INC Com Shs
BUY3.73%$77M3,603,595
DNTH
Dianthus Therapeutics INC
TRIM -30%3.52%$72M822,020
VRDN
Viridian Therapeutics INC
3.26%$67M3,257,917
VOR
Vor Biopharma INC
2.82%$58M3,041,719
COGT
Cogent Biosciences INC
2.55%$53M1,642,166
ANL
Adlai Nortye LTD
2.50%$51M3,212,731
JBIO
Jade Biosciences INC
2.20%$45M3,220,364
QUIT
Achieve Life Sciences INC
ADD +100%2.16%$44M5,502,064
MAZE
Maze Therapeutics
TRIM -4%2.04%$42M1,545,616
ORIC
Oric Pharmaceuticals INC
TRIM -32%1.93%$40M2,944,056
DYN
Dyne Therapeutics INC
1.70%$35M2,173,913
ADRX
Adarx Pharmaceuticals INC
BUY1.58%$32M1,625,793
CBIO
Crescent Biopharma INC.
1.51%$31M2,133,734
RLMD
Relmada Therapeutics INC
ADD +9%1.36%$28M7,445,050
ZURA
Zura Bio LTD
1.30%$27M6,434,990
XFOR
X4 Pharmaceuticals INC Com New
ADD +295%1.08%$22M7,644,072
CULLINAN ONCOL
Cullinan Oncology INC
1.03%$21M1,379,965
SRZN
Surrozen INC
0.99%$20M632,931
PBLS
Parabilis Medicines, INC.
0.98%$20M625,000
ARVN
Arvinas INC
BUY0.73%$15M1,952,533
IPSC
Century Therapeutics INC
0.72%$15M8,695,652
ENTX
Entera Bio LTD
BUY0.72%$15M5,106,337
ARTV
Artiva Biotherapeutics INC
0.71%$15M2,043,596
ANRO
Alto Neuroscience INC
0.62%$13M500,000
KRRO
Korro Bio INC
TRIM -56%0.21%$4M443,431
TCGX
Tcgx Acquisition Corp
BUY0.18%$4M300,000
RACD
Research Alliance Corp Iv
BUY0.17%$4M300,000
MTRI
Inmed Pharmaceuticals INC
ADD +308%0.01%$200k133,378
APOGEE THERA I
Apogee Thera INC
SELL0%was $1.1B0
GALECTO INC
Galecto INC
SELL0%was $94M0
ELVN
Enliven Therapeutics INC
SELL0%was $27M0
CYBIN INC
Cybin INC
SELL0%was $26M0
CTMX
Cytomx Therapeutics INC
SELL0%was $19M0
RACC
Research Alliance Corp III
SELL0%was $3M0

Copy return each quarter

HeldFund copyUS 500
2023-06-30 → 2023-09-30-20.7%-3.6%
2023-09-30 → 2023-12-31+21.4%+11.2%
2023-12-31 → 2024-03-31+54.4%+10.0%
2024-06-30 → 2024-09-30+20.7%+5.4%
2024-09-30 → 2024-12-31-19.7%+2.1%
2024-12-31 → 2025-03-31-24.9%-4.6%
2025-03-31 → 2025-06-30+13.5%+10.5%
2025-06-30 → 2025-09-30+32.7%+7.8%
2025-09-30 → 2025-12-31+51.7%+2.4%
2025-12-31 → 2026-03-31+24.3%-4.6%
2026-03-31 → 2026-06-30+33.0%+14.8%
2026-06-30 → 2026-09-30-7.5%+2.1%

The copy return buys the fund's reported stocks on the day after the filing became public and holds them for one quarter, so it measures what anyone reading the filings could have done.

All top 100 funds, live

Other top funds

Nextech Invest LTD.Fairmount Funds Management LLCTalos Eurisko Asset Management LPAnalog Century Management LPQvt Financial LPBroad Peak Investment Advisers Pte LTDWs Management LllpBvf INC/IlParadigm Biocapital Advisors LPOak Grove Capital LLCCm Wealth Advisors LLCAvidity Partners Management LPFirst Light Asset Management, LLCLogos Global Management LPSummit Street Capital Management, LLCMadison Avenue Partners, LPDivisar Capital Management LLCTcg Crossover Management, LLCOptimus Prime Fund Management Co., LTD.Value Aligned Research Advisors, LLCBraidwell LPRedmile Group, LLCOrbimed Advisors LLCMpm Bioimpact LLCCloudalpha Capital Management Limited/Hong KongGeneral Pension Society Pzu Joint Stock CoAmanah Holdings TrustSlate Path Capital LPDeep Track Capital, LP